KRISTAL RICHARDSON-AUBREY: Open Payments
NPI 1114470036 · LANSING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,639 in 93 payments from 23 companies in 2025. Trend: 2023 $1,473 · 2024 $1,639 · 2025 $1,639
Food & beverage: $1,639
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 10 | $263 |
| PFIZER INC. | 15 | $235 |
| AstraZeneca Pharmaceuticals LP | 2 | $171 |
| ABBVIE INC. | 12 | $154 |
| Axsome Therapeutics, Inc. | 6 | $139 |
| Amgen Inc. | 19 | $137 |
| Antares Pharma, Inc. | 4 | $75 |
| Novo Nordisk Inc | 4 | $71 |
| GlaxoSmithKline, LLC. | 3 | $58 |
| ViiV Healthcare Company | 2 | $43 |
Products named: FANAPT, Auvelity, OTEZLA, FARXIGA, NURTEC ODT, VRAYLAR, ELIQUIS, XYOSTED.
Industry payments across MI — which companies pay providers there.
